Company news
Edx Medical Group Plc (AQUIS:EDX) news
Edx Medical Group Plc news releases on 6ix. Latest, Oct 1, 2026: Investor Presentation Via Investor Meet Company
Press releases & updates
Investor Presentation Via Investor Meet Company
October 1, 2026
Result of AGM
September 28, 2026
Employee health contract with Arnold Clark Group
September 17, 2026
Director/PDMR shareholdings in the Company
September 4, 2026
Scottish Prostate Cancer Initiative update
August 27, 2026
Equity Fundraising of £2.7 million
August 24, 2026
Rapid pneumonia test deployed for NHS patients
August 3, 2026
Full launch of bowel cancer testing service (BC95)
July 21, 2026
Launch of employee health screening service
July 15, 2026
EDX Medical service agreement with Astron Health
July 8, 2026
Results of General Meeting
June 26, 2026
Posting of Notice of General Meeting
June 5, 2026
Rule 17 disclosure
June 4, 2026
First Day of Dealings on AIM
May 13, 2026
Granting of options over ordinary shares
April 21, 2026
Proposed application for admission to AIM
April 13, 2026
Total Voting Rights
April 1, 2026
Scottish Prostate Cancer Initiative
March 25, 2026
Exercise of Warrants
March 4, 2026
Total voting rights
February 27, 2026
Equity Fundraising raises £3.5 million
February 16, 2026
Director dealing
January 9, 2026
Interim report: Six months to 30 September 2025
December 19, 2025
Commercial launch of bowel cancer testing service
December 18, 2025
EDX Medical secures up to £4million funding
October 20, 2025
Advance testicular cancer testing service launched
October 7, 2025
Result of Annual General Meeting
September 29, 2025
Posting of Notice of AGM and Annual Report
September 1, 2025
Publication - Annual Report & Financial Statements
August 22, 2025
Partnership formed to provide new pneumonia test
August 8, 2025
Result of General Meeting
July 3, 2025
Posting of notice of General Meeting
June 17, 2025
Memorandum of Understanding with Spire Healthcare
June 16, 2025
‘Bed & ISA’ share transfer
April 15, 2025
New highly accurate testicular cancer test
April 11, 2025
Shareholdings update - REPLACEMENT
April 3, 2025
Shareholdings update
March 31, 2025
Equity Fundraising to raise £3.0 million
March 20, 2025
Service agreement with Royal Marsden NHS Trust
March 6, 2025
EDX develops new ‘super test’ for prostate cancer
February 17, 2025
Appointment of director & deputy chair
February 14, 2025
Interim Report: Six Months to Sep 30, 2024
December 16, 2024
Hardman & Co Video Event: EDX Medical (EDX) I...
November 12, 2024
Presentation to Aquis Showcase Event
November 7, 2024
New partnership to provide testicular cancer tests
November 6, 2024
Cancellation of warrants
November 1, 2024
Strategic investment via Placing of Shares
October 23, 2024
Annual General Meeting Results
September 30, 2024
Shareholder Update
September 9, 2024
Appointment of Chief Commercial Officer
September 5, 2024